Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-13

Clinical Trial Update: Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 study of AZD1305 in patients with left ventricular dysfunction completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD1305

Snippet

Sponsor: AstraZeneca | Conditions: Left Ventricle Function | Phase 2 | Status: COMPLETED | Results posted: 2011-06-13